Cargando…
The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders
New plant breeding technologies (NPBTs) are increasingly used for developing new plants with novel traits. The science tells us that those plants in general are as safe as than those once developed using “conventional” plant breeding methods. The knowledge about the induced changes and properties of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932994/ https://www.ncbi.nlm.nih.gov/pubmed/31921246 http://dx.doi.org/10.3389/fpls.2019.01597 |
_version_ | 1783483121939775488 |
---|---|
author | Wesseler, Justus Politiek, Hidde Zilberman, David |
author_facet | Wesseler, Justus Politiek, Hidde Zilberman, David |
author_sort | Wesseler, Justus |
collection | PubMed |
description | New plant breeding technologies (NPBTs) are increasingly used for developing new plants with novel traits. The science tells us that those plants in general are as safe as than those once developed using “conventional” plant breeding methods. The knowledge about the induced changes and properties of the new plants by using NPBTs is more precise. This should lead to the conclusion that plants developed using NPBTs should not be regulated differently than those developed using “conventional” plant breeding methods. This contribution discusses the economics of regulating new plant breeding technologies. We first develop the theoretical model and elaborate on the different regulatory approaches being used and compare their advantages and disadvantages. Then we provide a perspectives on EU regulation around mutagenesis-based New Plant Breeding Techniques (NPBT), formed by new insights from a survey among Dutch plant breeding companies. The survey measures the attitude of breeding companies towards the ruling of the EU Court of Justice that subjected the use of CRISPR-Cas in the development of new plant varieties under the general EU regulations around GMOs. The results show that plant breeders experience a financial barrier because of the ruling, with perceived negative impact on competitiveness and investments in CRISPR-Cas as a result. The degree of negative impact differs however significantly among seed-sectors and company sizes. One of the most striking results was the relative optimism of companies in the sector about more lenient legislation in the next five years, despite the stated negative effects. |
format | Online Article Text |
id | pubmed-6932994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69329942020-01-09 The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders Wesseler, Justus Politiek, Hidde Zilberman, David Front Plant Sci Plant Science New plant breeding technologies (NPBTs) are increasingly used for developing new plants with novel traits. The science tells us that those plants in general are as safe as than those once developed using “conventional” plant breeding methods. The knowledge about the induced changes and properties of the new plants by using NPBTs is more precise. This should lead to the conclusion that plants developed using NPBTs should not be regulated differently than those developed using “conventional” plant breeding methods. This contribution discusses the economics of regulating new plant breeding technologies. We first develop the theoretical model and elaborate on the different regulatory approaches being used and compare their advantages and disadvantages. Then we provide a perspectives on EU regulation around mutagenesis-based New Plant Breeding Techniques (NPBT), formed by new insights from a survey among Dutch plant breeding companies. The survey measures the attitude of breeding companies towards the ruling of the EU Court of Justice that subjected the use of CRISPR-Cas in the development of new plant varieties under the general EU regulations around GMOs. The results show that plant breeders experience a financial barrier because of the ruling, with perceived negative impact on competitiveness and investments in CRISPR-Cas as a result. The degree of negative impact differs however significantly among seed-sectors and company sizes. One of the most striking results was the relative optimism of companies in the sector about more lenient legislation in the next five years, despite the stated negative effects. Frontiers Media S.A. 2019-12-20 /pmc/articles/PMC6932994/ /pubmed/31921246 http://dx.doi.org/10.3389/fpls.2019.01597 Text en Copyright © 2019 Wesseler, Politiek and Zilberman http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Plant Science Wesseler, Justus Politiek, Hidde Zilberman, David The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders |
title | The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders |
title_full | The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders |
title_fullStr | The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders |
title_full_unstemmed | The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders |
title_short | The Economics of Regulating New Plant Breeding Technologies - Implications for the Bioeconomy Illustrated by a Survey Among Dutch Plant Breeders |
title_sort | economics of regulating new plant breeding technologies - implications for the bioeconomy illustrated by a survey among dutch plant breeders |
topic | Plant Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932994/ https://www.ncbi.nlm.nih.gov/pubmed/31921246 http://dx.doi.org/10.3389/fpls.2019.01597 |
work_keys_str_mv | AT wesselerjustus theeconomicsofregulatingnewplantbreedingtechnologiesimplicationsforthebioeconomyillustratedbyasurveyamongdutchplantbreeders AT politiekhidde theeconomicsofregulatingnewplantbreedingtechnologiesimplicationsforthebioeconomyillustratedbyasurveyamongdutchplantbreeders AT zilbermandavid theeconomicsofregulatingnewplantbreedingtechnologiesimplicationsforthebioeconomyillustratedbyasurveyamongdutchplantbreeders AT wesselerjustus economicsofregulatingnewplantbreedingtechnologiesimplicationsforthebioeconomyillustratedbyasurveyamongdutchplantbreeders AT politiekhidde economicsofregulatingnewplantbreedingtechnologiesimplicationsforthebioeconomyillustratedbyasurveyamongdutchplantbreeders AT zilbermandavid economicsofregulatingnewplantbreedingtechnologiesimplicationsforthebioeconomyillustratedbyasurveyamongdutchplantbreeders |